BIENAIME JEAN JACQUES

CIK 00012215908 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001221590

Recent Transactions

50 trades

Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-06-03+17,600→ 17,600 total
Award
Keros Therapeutics, Inc.$KROS
Stock Option (right to buy)
2024-06-03+17,600→ 17,600 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-12-16−6,000→ 125,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-12-16$84.68/sh−6,000→ 303,689 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-12-16$37.46/sh+6,000→ 309,689 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-12-15−6,000→ 131,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-12-15$82.71/sh−6,000→ 303,689 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-12-15$37.46/sh+6,000→ 309,689 total
Gift
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-12-10−700→ 303,689 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-16$77.21/sh−5,559→ 308,017 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-16$77.21/sh−5,559→ 308,017 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-15$78.39/sh−23,426→ 313,576 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-15+41,350→ 337,002 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-15$78.39/sh−23,426→ 313,576 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2021-03-15+41,350→ 337,002 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-03-15+101,820→ 101,820 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2021-03-15+101,820→ 101,820 total
Award
INCYTE CORP$INCY
Common Stock
2020-06-30$103.97/sh+208→ 9,190 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-12-28$84.04/sh−3,000→ 288,290 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-12-28$14.39/sh+3,000→ 291,290 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-12-28$14.39/sh+3,000→ 291,290 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2018-12-28−3,000→ 92,000 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-12-28$84.04/sh−3,000→ 288,290 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2018-12-28−3,000→ 92,000 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2018-06-04$92.07/sh−6,310→ 284,290 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-06-05$17.33/sh+5,000→ 231,924 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-06-05$90.56/sh−5,000→ 226,924 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2017-06-05−5,000→ 0 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (Right to buy Common Stock)
2017-06-02−5,000→ 5,000 total
Tax Payment
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-06-02$90.72/sh−6,640→ 226,924 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-06-02$89.70/sh−5,000→ 233,564 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2017-06-02$17.33/sh+5,000→ 238,564 total
Purchase
INCYTE CORP$INCY
Common Stock
2017-04-13$139.66/sh+1,000→ 3,177 total
Purchase
INCYTE CORP$INCY
Common Stock
2017-04-13$139.66/sh+1,000→ 3,177 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy Common Stock)
2016-12-30−4,000→ 109,423 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-30$17.33/sh+4,000→ 174,682 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy Common Stock)
2016-12-30−4,000→ 109,423 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-30$83.35/sh−4,000→ 170,682 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-30$83.35/sh−4,000→ 170,682 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-30$17.33/sh+4,000→ 174,682 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy Common Stock)
2016-12-29−4,000→ 113,423 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy Common Stock)
2016-12-29−4,000→ 113,423 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-29$17.33/sh+4,000→ 174,682 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-29$83.84/sh−4,000→ 170,682 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-29$83.84/sh−4,000→ 170,682 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-12-29$17.33/sh+4,000→ 174,682 total
Sale
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-09-16$95.25/sh−53,125→ 378,584 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-09-16$38.59/sh+53,125→ 431,709 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Stock Option (right to buy Common Stock)
2016-09-16−41,666→ 83,336 total
Exercise/Conversion
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2016-09-16$17.54/sh+41,666→ 420,250 total

Companies

Recent Filings

Address

C/O KEROS THERAPEUTICS, INC. 1050 WALTHAM STREET, SUITE 302

LEXINGTON, MA, 02421

View on SEC.gov